Nevertheless our data demonstrates that S1P production controlled by SPHK1 and SGPL1 are key determinants of cytotoxic drug resistance and that decreasing S1P production in cancer cells could lead to increased cytotoxic sensitivity. This evidence concerns the gene SPHK1 and cancer.